Picture of IGEA Pharma NV logo

IGPH IGEA Pharma NV News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Swiss stocks - Factors to watch on October 22

ZURICH/BERLIN, Oct 22 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
    
    CORONAVIRUS
    High-level negotiations on a new coronavirus aid bill faced
a setback when U.S. President Donald Trump accused Democrats of
being unwilling to craft an acceptable compromise.  urn:newsml:reuters.com:*:nL1N2HC1JV
    The number of confirmed coronavirus cases in Germany rose by
more than 10,000 in a single day for the first time.
 urn:newsml:reuters.com:*:nL8N2HD086
    Over half the small and medium-sized companies which
together provide jobs for two-thirds of European workers fear
for their survival in the coming 12 months, according to a
survey released by management consultancy McKinsey.  urn:newsml:reuters.com:*:nL8N2HC6JO
    
    
    SIKA  SIKA.S 
    The construction chemicals maker reported a drop in profit
and sales during the first nine months of 2020, as many
construction activities were halted due to the COVID-19
pandemic.  urn:newsml:reuters.com:*:nL4N2HD0ZN
    
    CREDIT SUISSE  CSGN.S 
    Mozambique's Attorney General's Office said it will seek the
extradition of three former Credit Suisse bankers implicated in
a $2 billion debt scandal that sent the country's economy into
crisis.  urn:newsml:reuters.com:*:nL8N2HC6C9
    
    UBS  UBSG.S 
    Outgoing CEO Sergio Ermotti has agreed to serve as chairman
of special purpose acquisition company Investindustrial
Acquisition, according to a U.S. filing.  urn:newsml:reuters.com:*:nL4N2HC4Y7
    
      
    COMPANY STATEMENTS
    * Stadler Rail  SRAIL.S  announced a €158 million order https://bit.ly/34kVhkI
 from Portugal.
    * Huber+Suhner  HUBN.S  confirmed its full-year outlook and
said https://www.hubersuhner.com/en/company/media/news/3969 its
business continues to stabilise.
    * Implenia  IMPN.S  said Swiss Prime Site  SPSN.S  has
awarded the company a mandate for the construction of the
Pont-Rouge project near Geneva and added the order is worth
around 132 million Swiss francs.  urn:newsml:reuters.com:*:nTENrtr0oa
    * Wisekey  WIHN.S  said it signed a deal with U.S. company
Allscripts to protect its healthcare systems.  urn:newsml:reuters.com:*:nGNX6NPDff
    * IGEA Pharma  IGPH.S  announced the resignation of Mark De
Simone from the board of directors.  urn:newsml:reuters.com:*:nEQbdKfPpa
    
    
    ANALYSTS' VIEWS
    NESTLE  NESN.S  - Credit Suisse raises target price to CHF
102 from CHF 100
    LOGITECH  LOGN.S  - Credit Suisse raises target price to CHF
101 from CHF 75
    VIFOR PHARMA  VIFN.S  - Credit Suisse cuts target price to
CHF 149 from CHF 152
    
    
    ECONOMY
    No major Swiss economic data scheduled
    

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))

Recent news on IGEA Pharma NV

See all news